KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Operating Leases (2019 - 2025)

Edwards Lifesciences (EW) has 7 years of Operating Leases data on record, last reported at $107.1 million in Q4 2025.

  • For Q4 2025, Operating Leases rose 35.74% year-over-year to $107.1 million; the TTM value through Dec 2025 reached $107.1 million, up 35.74%, while the annual FY2025 figure was $107.1 million, 35.74% up from the prior year.
  • Operating Leases reached $107.1 million in Q4 2025 per EW's latest filing, up from $75.3 million in the prior quarter.
  • Across five years, Operating Leases topped out at $107.1 million in Q4 2025 and bottomed at $63.5 million in Q2 2022.
  • Average Operating Leases over 5 years is $73.9 million, with a median of $69.8 million recorded in 2022.
  • Peak YoY movement for Operating Leases: decreased 26.53% in 2022, then skyrocketed 35.74% in 2025.
  • A 5-year view of Operating Leases shows it stood at $94.6 million in 2021, then fell by 26.53% to $69.5 million in 2022, then fell by 6.19% to $65.2 million in 2023, then grew by 21.01% to $78.9 million in 2024, then soared by 35.74% to $107.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Leases were $107.1 million in Q4 2025, $75.3 million in Q3 2025, and $78.7 million in Q2 2025.